Villin is a biomarker for reverse polarity in colorectal micropapillary carcinoma

Zhao,Li; Liu,Shao-Yan; Li,Yu-Meng; Xiong,Zhong-Tang

doi:10.3892/ol.2020.12333

Villin is a biomarker for reverse polarity in colorectal micropapillary carcinoma

Authors:
- Li Zhao
- Shao-Yan Liu
- Yu-Meng Li
- Zhong-Tang Xiong
View Affiliations

Affiliations: Department of Pathology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China
Published online on: November 25, 2020 https://doi.org/10.3892/ol.2020.12333
Article Number: 72
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is a common malignant tumor of digestive system. CRC with micropapillary pattern (MPP) is an aggressive variant of colorectal adenocarcinoma. The aim of the present study was to clarify the clinicopathological significance and the prognostic role of an immunohistochemical marker, MPP, in CRC. The association between MPP and clinicopathological characteristics and prognosis in 286 cases of CRC (286/453 cases had follow‑up information) were analysed. Then, 81 tissues without MPP and 90 tissues with MPP were analysed by immunohistochemistry using antibodies against villin, E‑cadherin and epithelial membrane antigen (EMA). Bioinformatics was used to evaluate the expression of these three indicators in CRC. The proportion of micropapillary carcinoma in the overall tumour was ≥5%, and was observed in 90/453 cases (19.8%). The present data showed that CRC with MPP displayed higher rates of vascular and lymphatic invasion, a higher metastatic lymph node ratio and a higher pathological tumour and metastasis stage compared with CRC without MPP. The positive expression rates of EMA, E‑cadherin and villin were 50.3, 93.4 and 96.5%, respectively. In 90 CRC cases with MPP, EMA inside‑out pattern (I/OP) staining was observed in 26 cases (28.9%), and it was often focal and partial, while 37 cases (41.1%) had E‑cadherin focal and partial staining compatible with reverse polarity. Villin I/OP staining was observed in 77 cases (85.6%), and circumferential staining predominated over partial staining. Overall, the data suggested that the presence of MPP is significantly associated with aggressive tumour behaviour and worse overall survival rate in CRC. Visualization and distinction of reverse polarity of colorectal micropapillary carcinomas is improved villin compared with EMA or E‑cadherin.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Tauriello DV, Calon A, Lonardo E and Batlle E: Determinants of metastatic competency in colorectal cancer. Mol Oncol. 11:97–119. 2017. View Article : Google Scholar : PubMed/NCBI
3	Remo A, Fassan M, Vanoli A, Bonetti LR, Barresi V, Tatangelo F, Gafà R, Giordano G, Pancione M, Grillo F, et al: Morphology and molecular features of rare colorectal carcinoma histotypes. Cancers (Basel). 11:E10362019. View Article : Google Scholar : PubMed/NCBI
4	Guo Z, Yang Z, Li D, Tang J, Xu J, Shen H and Yuan Y: Colorectal cancer with invasive micropapillary components (IMPCs) shows high lymph node metastasis and a poor prognosis: A retrospective clinical study. Medicine (Baltimore). 99:e202382020. View Article : Google Scholar : PubMed/NCBI
5	Muratsu A, Noura S, Matsumura T, Hirota M, Yasuyama H, Koga C, Takata A, Kameda C, Murakami M, Kawabata R, et al: A colorectal cancer with invasive micropapillary carcinoma. Gan To Kagaku Ryoho. 44:1814–1816. 2017.(In Japanese). PubMed/NCBI
6	Haupt B, Ro JY, Schwartz MR and Shen SS: Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis. Mod Pathol. 20:729–733. 2007. View Article : Google Scholar : PubMed/NCBI
7	Patankar M, Väyrynen S, Tuomisto A, Mäkinen M, Eskelinen S and Karttunen TJ: Micropapillary structures in colorectal cancer: An anoikis-resistant subpopulation. Anticancer Res. 38:2915–2921. 2018.PubMed/NCBI
8	Fujita T, Konishi M, Gotohda N, Takahashi S, Nakagohri T, Kojima M and Kinoshita T: Invasive micropapillary carcinoma of the ampulla of Vater with extensive lymph node metastasis: Report of a case. Surg Today. 40:1197–1200. 2010. View Article : Google Scholar : PubMed/NCBI
9	Vardar E, Yardim BG, Vardar R and Ölmez M: Primary gastric invasive micropapillary carcinoma: A case report. Turk Patoloji Derg. 31:219–222. 2015.PubMed/NCBI
10	Ushiku T, Matsusaka K, Iwasaki Y, Tateishi Y, Funata N, Seto Y and Fukayama M: Gastric carcinoma with invasive micropapillary pattern and its association with lymph node metastasis. Histopathology. 59:1081–1089. 2011. View Article : Google Scholar : PubMed/NCBI
11	Wen P, Xu Y, Frankel WL and Shen R: Invasive micropapillary carcinoma of the sigmoid colon: Distinct morphology and aggressive behavior. Int J Clin Exp Pathol. 1:457–460. 2008.PubMed/NCBI
12	Collins K and Ricci A Jr: Micropapillary variant of mucinous breast carcinoma: A distinct subtype. Breast J. 24:339–342. 2018. View Article : Google Scholar : PubMed/NCBI
13	Young RH: Ovarian tumors: A survey of selected advances of note during the life of this journal. Hum Pathol. 95:169–206. 2020. View Article : Google Scholar : PubMed/NCBI
14	Shinagawa T, Hoshino H, Taga M, Sakai Y, Imamura Y, Yokoyama O and Kobayashi M: Clinicopathological implications to micropapillary bladder urothelial carcinoma of the presence of sialyl Lewis X-decorated mucin 1 in stroma-facing membranes. Urol Oncol. 35:606.e17–606.e23. 2017. View Article : Google Scholar
15	Guzińska-Ustymowicz K, Niewiarowska K and Pryczynicz A: Invasive micropapillary carcinoma: A distinct type of adenocarcinomas in the gastrointestinal tract. World J Gastroenterol. 20:4597–4606. 2014. View Article : Google Scholar : PubMed/NCBI
16	Monroig-Bosque PDC, Morales-Rosado JA, Roden AC, Churg A, Barrios R, Cagle P, Ge Y, Allen TC, Smith ML, Larsen BT, et al: Micropapillary adenocarcinoma of lung: Morphological criteria and diagnostic reproducibility among pulmonary pathologists. Ann Diagn Pathol. 41:43–50. 2019. View Article : Google Scholar : PubMed/NCBI
17	Otsuru M, Aoki T, Kondo Y, Ota Y, Sasaki M, Suzuki T, Ogura G and Kumaki N: Salivary duct carcinoma with invasive micropapillary and rhabdoid feature arising in the submandibular gland. Tokai J Exp Clin Med. 42:30–36. 2017.PubMed/NCBI
18	Kitagawa H, Yoshimitsu M, Kaneko M, Ibuki Y, Emi M, Kohashi T, Mukaida H, Matsuura H, Ohge H, Ohdan H, et al: Invasive micropapillary carcinoma component is an independent prognosticator of poorer survival in Stage III colorectal cancer patients. Jpn J Clin Oncol. 47:1129–1134. 2017. View Article : Google Scholar : PubMed/NCBI
19	Kuroda N and Yorita K: Colon cancer with micropapillary carcinoma component: A clinopathologic study of 9 cases. Pol J Pathol. 68:102–108. 2017. View Article : Google Scholar : PubMed/NCBI
20	Cserni G: Reversed polarity of the glandular epithelial cells in micropapillary carcinoma of the large intestine and the EMA/MUC₁ immunostain. Pathology. 46:527–532. 2014. View Article : Google Scholar : PubMed/NCBI
21	Alsadoun N, MacGrogan G, Truntzer C, Lacroix-Triki M, Bedgedjian I, Koeb MH, Alam EEl, Medioni D, Parent M, Wuithier P, et al: Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: A comparative study of 9 additional cases. Mod Pathol. 31:1367–1380. 2018. View Article : Google Scholar : PubMed/NCBI
22	Lotan TL, Ye H, Melamed J, Wu XR, Shih IeM and Epstein JI: Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am J Surg Pathol. 33:1037–1041. 2009. View Article : Google Scholar : PubMed/NCBI
23	Terada T: An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC₁, MUC₂, MUC₅AC, and MUC₆ in normal mucosa and in 42 cases. Int J Clin Exp Pathol. 6:613–621. 2013.PubMed/NCBI
24	Park SY, Lee HS, Choe G, Chung JH and Kim WH: Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location. Virchows Arch. 449:40–47. 2006. View Article : Google Scholar : PubMed/NCBI
25	Duncan TJ, Watson NF, AI-Attar AH, Scholefield JH and Durrant LG: The role of MUC₁ and MUC₃ in the biology and prognosis of colorectal cancer. World J Surg Oncol. 5:312007. View Article : Google Scholar : PubMed/NCBI
26	Wang Y, Srinivasan K, Siddiqui MR, George SP, Tomar A and Khurana S: A novel role for villin in intestinal epithelial cell survival and homeostasis. J Biol Chem. 283:9454–9464. 2008. View Article : Google Scholar : PubMed/NCBI
27	Gonzalez RS, Huh WJ, Cates JM, Washington K, Beauchamp RD, Coffey RJ and Shi C: Micropapillary colorectal carcinoma: Clinical, pathological and molecular properties, including evidence of epithelial-mesenchymal transition. Histopathology. 70:223–231. 2017. View Article : Google Scholar : PubMed/NCBI
28	Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
29	Wilson LA, Heraty L, Ashford BA, Coelho S, Frangi AF, Pozo JM, Ince PG and Highley JR: Tissue microarray (TMA) use in post mortem neuropathology. J Neurosci Methods. 347:1089632020. View Article : Google Scholar : PubMed/NCBI
30	Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et al: A pathology atlas of the human cancer transcriptome. Science. 357:eaan25072017. View Article : Google Scholar : PubMed/NCBI
31	Eom DW, Kang GH, Han SH, Cheon GJ, Han KH, Oh HS, Kim JH, Jang HJ and Hong SM: Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II. Am J Surg Pathol. 35:84–91. 2011. View Article : Google Scholar : PubMed/NCBI
32	Hattori T, Sentani K, Hattori Y, Oue N and Yasui W: Pure invasive micropapillary carcinoma of the esophagogastric junction with lymph nodes and liver metastasis. Pathol Int. 66:583–586. 2016. View Article : Google Scholar : PubMed/NCBI
33	Lee HJ, Eom DW, Kang GH, Han SH, Cheon GJ, Oh HS, Han KH, Ahn HJ, Jang HJ and Han MS: Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells. Mod Pathol. 26:1123–1131. 2013. View Article : Google Scholar : PubMed/NCBI
34	Xu F, Xu J, Lou Z, Di M, Wang F, Hu H and Lai M: Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T₁ and T₂ stages and decreased survival time in TNM stages I and II. Am J Surg Pathol. 33:1287–1292. 2009. View Article : Google Scholar : PubMed/NCBI
35	Verdú M, Román R, Calvo M, Rodón N, García B, González M, Vidal A and Puig X: Clinicopathological and molecular characterization of colorectal micropapillary carcinoma. Mod Pathol. 24:729–738. 2011. View Article : Google Scholar : PubMed/NCBI
36	Miyazaki M, Aoki M, Okado Y, Koga K, Hamasaki M, Kiyomi F, Sakata T, Nakagawa T and Nabeshima K: Poorly differentiated clusters predict a poor prognosis for external auditory canal carcinoma. Head Neck Pathol. 13:198–207. 2019. View Article : Google Scholar : PubMed/NCBI
37	Barresi V, Branca G, Vitarelli E and Tuccari G: Micropapillary pattern and poorly differentiated clusters represent the same biological phenomenon in colorectal cancer: A proposal for a change in terminology. Am J Clin Pathol. 142:375–383. 2014. View Article : Google Scholar : PubMed/NCBI
38	Zlobec I and Lugli A: Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget. Oncotarget. 1:651–661. 2010. View Article : Google Scholar : PubMed/NCBI
39	Lino-Silva LS, Salcedo-Hernández RA and Caro-Sánchez CH: Colonic micropapillary carcinoma, a recently recognized subtype associated with histological adverse factors: Clinicopathological analysis of 15 cases. Colorectal Dis. 14:e567–e572. 2012. View Article : Google Scholar : PubMed/NCBI
40	Yang YL, Liu BB, Zhang X and Fu L: Invasive micropapillary carcinoma of the breast: An update. Arch Pathol Lab Med. 140:799–805. 2016. View Article : Google Scholar : PubMed/NCBI
41	Dalle Vedove A, Falchi F, Donini S, Dobric A, Germain S, Di Martino GP, Prosdocimi T, Vettraino C, Torretta A, Cavalli A, et al: Structure-based virtual screening allows the identification of efficient modulators of e-cadherin-mediated cell-cell adhesion. Int J Mol Sci. 20:E34042019. View Article : Google Scholar : PubMed/NCBI
42	Revenu C, Courtois M, Michelot A, Sykes C, Louvard D and Robine S: Villin severing activity enhances actin-based motility in vivo. Mol Biol Cell. 18:827–838. 2007. View Article : Google Scholar : PubMed/NCBI